OGN

What one share of Organon holds

Pharmaceutical Preparations

Organon & Co. (“Organon,” the “Company,” “we,” “our,” or “us”) is a global healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day.

Organon’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.

Per-share figures
Sales$23.23
Profit$0.79
Capex (buildings and equipment)$0.64
Free cash flow$2.15
Dividends$0.08
Cash and investments$4.31
Debt$32.29
Book value$3.83

Per share by fiscal year

YearSalesProfitCapexFree cashDividendsBook value
2019$30.68$12.69$0.36$11.55—$27.75
2020$25.77$8.52$1.01$8.00—$21.64
2021$24.80$5.31$0.76$7.74$0.56−$5.95
2022$24.20$3.59$0.77$2.59$1.12−$3.51
2023$24.44$3.99$0.98$2.14$1.12−$0.27
2024$24.71$3.33$0.68$2.95$1.12$1.83
2025$23.84$0.72$0.62$2.06$0.34$2.89

Common questions about Organon

How much does one share of Organon earn?

Over the last 12 months, each share of Organon earned $0.79 of profit on $23.23 of sales, keeping about 3¢ of every $1 (profit margin).

Does Organon pay a dividend?

Yes. Organon paid $0.08 per share in dividends over the last 12 months, and it paid a dividend in every year from 2021 to 2025 in StockSlicer’s data. That’s about 10¢ of each $1 of profit (payout ratio).

What is Organon’s book value per share?

Organon’s book value is $3.83 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.

How much cash and debt does each share of Organon have?

Each share of Organon has $4.31 of cash and investments and $32.29 of debt, as of June 30, 2026.

What is Organon’s free cash flow per share?

$2.15 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.

How has Organon’s profit per share changed over time?

Profit per share went from $12.69 in 2019 to $0.72 in 2025, shrinking about 38.1% a year (adjusted for stock splits).

From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.